Globus Medical Inc. logo

GMED

Globus Medical Inc. · NYSE

Website
Market cap
$9.34B
EPS (TTM)
$4.05
Shares out
132.5M

Globus Medical Inc. (GMED) is a Medical/Dental Instruments company listed on NYSE. In the last 30 days Quantisnow tracked 9 wire items for GMED, including 3 SEC filings, 2 insider trades and 1 M&A update. The most recent was published Nov 12, 2026.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED rankings

Financial highlights

Full financials
Revenue, TTM
$3.14B
Revenue growth
+13.4%
Net income, TTM
$557.64M
Net margin
17.8%
Free cash flow, TTM
$766.55M
Cash
$441.27M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks27+800%
2026-05-24: 12026-05-31: 12026-06-07: 22026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 12026-07-12: 12026-07-19: 02026-07-26: 22026-08-02: 32026-08-09: 02026-08-16: 22026-08-23: 12026-08-30: 12026-09-06: 02026-09-13: 22026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 12026-10-18: 02026-10-25: 02026-11-01: 62026-11-08: 32026-11-15: 0
2026-05-242026-11-15
Mix1490d
  • SEC Filings4(29%)
  • Insider3(21%)
  • M&A2(14%)
  • Other2(14%)
  • Earnings2(14%)
  • Analyst1(7%)
Activity · 52 weeks6741 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

GMED FAQ

11 questions
  • What does Globus Medical Inc. do?
    Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral...
  • What is the latest news on GMED?
    In the last 30 days Quantisnow tracked 9 wire items for GMED: 3 SEC filings, 2 insider trades, 1 M&A update and 1 earnings update. The most recent was published on November 12, 2026.
  • What is GMED revenue?
    Globus Medical Inc. (GMED) reported $3.14B of revenue for the twelve months ended Sep 30, 2026. That is up 13.4% from the year before. Revenue for fiscal 2025 was $2.94B.
  • Is GMED profitable?
    Yes. Globus Medical Inc. earned $557.64M in net income for the twelve months ended Sep 30, 2026, a net margin of 17.8%.
  • How much cash and debt does GMED have?
    Globus Medical Inc. reported $441.27M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does GMED stock trade?
    Globus Medical Inc. (GMED) is listed on NYSE.
  • What sector and industry is GMED in?
    Globus Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
  • When did Globus Medical Inc. go public?
    Globus Medical Inc. (GMED) completed its IPO in 2012.
  • What are analysts saying about GMED?
    Across the last 8 analyst actions on Globus Medical Inc., there were 3 upgrades and 1 downgrade. The most recent action was from BMO Capital Markets: Market Perform with a $78.00 price target on 2026-11-06. Recent price targets range from $64.00 to $112.00.
  • What companies are similar to GMED?
    Notable peers in the same industry include ZBH (Zimmer Biomet Holdings Inc.), MDT (Medtronic plc.), OFIX (Orthofix Medical Inc.), SYK (Stryker Corporation), ATEC (Alphatec Holdings Inc.). Compare GMED side-by-side with any of them on Quantisnow.
  • How can I track GMED on Quantisnow?
    Quantisnow aggregates Globus Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GMED to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change